Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
May 17 2022 - 09:09AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
Report
of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16
Under
the Securities Exchange Act of 1934
For
the Month of May 2022
001-36345
(Commission
File Number)
GALMED
PHARMACEUTICALS LTD.
(Exact
name of Registrant as specified in its charter)
16
Tiomkin St.
Tel
Aviv 6578317, Israel
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover
Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7): ☐
Galmed
Pharmaceuticals Ltd. (the “Company”) announces that it will hold an Annual General Meeting of Shareholders on Wednesday,
June 22, 2022 at 5:00 p.m. (Israel time) at the offices of the Company at 16 Tiomkin St., Tel Aviv, Israel. A copy of the Notice of the
Annual General Meeting of Shareholders and Proxy Statement and the Proxy Card are attached hereto as Exhibit 99.1 and Exhibit 99.2, respectively,
and are incorporated herein by reference.
This
Form 6-K is incorporated by reference into the Company’s Registration Statements on Form S-8 (Registration No. 333-206292
and 333-227441) and the Company’s Registration Statement on Form F-3 (Registration No. 333-254766).
Exhibit
Index
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
Galmed
Pharmaceuticals Ltd. |
|
|
|
Date:
May 17, 2022 |
By: |
/s/
Allen Baharaff |
|
|
Allen
Baharaff |
|
|
President
and Chief Executive Officer |
Galmed Pharmaceuticals (NASDAQ:GLMD)
Historical Stock Chart
From Feb 2024 to Mar 2024
Galmed Pharmaceuticals (NASDAQ:GLMD)
Historical Stock Chart
From Mar 2023 to Mar 2024